This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Picano, E. Articles by L'Abbate, A. Search for Related Content PubMed PubMed Citation Articles by Picano, E. Articles by L'Abbate, A. Social Bookmarking                         What's this?

Increase of Walking Capacity After Acute Aminophylline Administration in Intermittent Claudication

C.N.R. Clinical Physiology Institute and Patologia Medica, University of Pisa

Roberto Testa

C.N.R. Clinical Physiology Institute and Patologia Medica, University of Pisa

Mauro Pogliani

Divisione di Cardiologia, Ospedale di Lucca, Lucca, Italy

Fabio Lattanzi

C.N.R. Clinical Physiology Institute and Patologia Medica, University of Pisa

Vincenzo Gaudio

C.N.R. Clinical Physiology Institute and Patologia Medica, University of Pisa

Antonio L'Abbate

C.N.R. Clinical Physiology Institute and Patologia Medica, University of Pisa

In the presence of peripheral atherosclerotic disease, inappropriate adeno sine release during exercise might promote excessive arteriolar dilation leading to steal phenomena and ischemia.

In order to test this hypothesis, IV aminophylline (6 mg/kg over fifteen min utes), a dosage known to effectively block adenosine receptors, was acutely ad ministered—in a double-blind, placebo-controlled study design—in 13 patients with intermittent claudication and documented atherosclerotic disease. All pa tients performed two treadmill exercise tests at the same hour on two consecu tive days, five minutes after aminophylline or placebo administration randomly allocated. Pain-free time was 109±133 (mean±SD) seconds after placebo and 173±165 seconds after aminophylline (p < .01); maximum time to claudication was 273±191 seconds after placebo and 397±318 seconds after aminophylline (p < .05).

The authors conclude that intravenous aminophylline markedly increases the walking capacity in patients with intermittent claudication, possibly by pre venting flow maldistribution phenomena through adenosine receptors block ade.

Angiology, Vol. 40, No. 12, 1035-1039 (1989)
DOI: 10.1177/000331978904001203


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?